check_circleStudy Completed

Common Cold, Sore Throat

ASPIRIN, relative bioavailability caplet vs. granules

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 45 Years
  • -

  • -

Trial summary

Enrollment Goal
25
Trial Dates
October 2004 - November 2004
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Aspirin (Acetylsalicylic Acid, BAYE4465)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Institut für Klinische Pharmakologie, Prof. Lücker GmbHMannheim, 68167, Germany

Trial design

Open, randomized three-factorial (treatment-period-sequence), two-treatment, two-period, cross-over clinical bioequivalence-study for comparison of a fixed combination of 500 mg acetylsalicylic acid/30 mg pseudoephedrine (granules) versus a newly developed caplet formulation containing 500 mg acetylsalicylic acid/30 mg pseudoephedrine in 24 healthy male volunteers
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A